Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
6 Savvy Locks for Lofts - 2Smoking rate among US adults drops to record low as vape use rises, CDC report finds
- 3Inflammatory Merz remarks on migrants' violence against women slammed
- 4The Most Rousing Ladies Business visionaries of Today
- 5Europe’s EV Boom Was Real in 2025. The Real Fight Starts In 2026
- The Iran war’s energy security legacy
- Starfront Observatories: A haven for distant stargazers
- Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
- Europe picks companies to help build Argonaut moon lander
- Warming winters lead to more nitrate pollution in the drinking water near farms
- He made a name for himself posting thirst traps on TikTok. Now he's the star of a wildly popular rom-com.
- Famous Kitchen Finishing Styles For 2024
- Italian court approves extradition to Germany of Ukrainian suspect in Nord Stream pipeline blast
- Poll: Most are satisfied with their health insurance, but a quarter report denials or delays
